Skip to main content
The FiscalWire

XERS

NASDAQ-GS

Xeris Biopharma Holdings, Inc. Common Stock

$15.20
+2.12 (+16.21%)

XERS Price Chart

Price Chart

XERS Key Statistics

Key financial metrics and statistics for XERS stock including valuation ratios, earnings data, ownership breakdown, and technical indicators.
IndexNASDAQP/E-EPS (ttm)-0.05Insider Own5.05%Shs Outstand182.57MPerf Week41.92%
Market Cap2.78BForward P/E37.91EPS next Y-Inst Own61.43%Shs Float173.47MPerf Month49.17%
Income-48,928,000PEG-EPS this Y1597.14%Short Float4.63%Short Ratio3.14Perf Quart90.24%
Sales368.70MP/S7.54EPS next Y%0.40%ROA-1.64%52W High$13.74 10.63%Perf Half Y132.77%
Book/sh0.27P/B56.88EPS next 5Y-ROE-27.11%52W Low$5.25 189.52%Perf Year97.15%
Cash/sh0.72P/FCF-EPS past 5Y-Gross Margin84.44%Volatility7.92% 5.32%Beta0.77
Dividend-EV/EBITDA-Sales past 5Y-Oper. Margin12.70%ATR (14)0.79Target Price$16.71
Dividend %-EV/Sales-Sales Q/Q44.16%Profit Margin-1.76%RSI (14)82.39Avg Volume2.55M
Employees435Quick Ratio1.58EPS Q/Q1597.14%SMA2040.25%Rel Volume3.10Prev Close$13.08
Payout0.00%Current Ratio2.15Earnings-SMA5057.93%Volume7.90MPrice$15.20
Recom1.38Debt/Eq0.05Analysts-SMA20099.81%-Change1621.00%

Recent News: XERS